in this issue
Regions :: Western Europe
Perrigo completes acquisition of Elan for $8.6 billion
8:09 AM MST | December 19, 2013 | Deepti Ramesh
Health-care products firm Perrigo (Allegan, MI) says that it has completed the previously announced acquisition of biotechnology company Elan (Dublin), for about $8.6 billion. Perrigo and Elan have been combined under a new company incorporated in Ireland and have adopted the global name Perrigo Co. plc. Shares of Perrigo will trade on the New York Stock Exchange and the Tel Aviv Stock Exchange. “The combined company establishes a diversified platform that will position Perrigo well for further expansion,” says Joseph Papa, Perrigo chairman and CEO...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be: